1. Home
  2. RVP vs CARA Comparison

RVP vs CARA Comparison

Compare RVP & CARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVP
  • CARA
  • Stock Information
  • Founded
  • RVP 1994
  • CARA 2004
  • Country
  • RVP United States
  • CARA United States
  • Employees
  • RVP N/A
  • CARA N/A
  • Industry
  • RVP Medical/Dental Instruments
  • CARA Biotechnology: Pharmaceutical Preparations
  • Sector
  • RVP Health Care
  • CARA Health Care
  • Exchange
  • RVP Nasdaq
  • CARA Nasdaq
  • Market Cap
  • RVP 18.6M
  • CARA 16.7M
  • IPO Year
  • RVP 2001
  • CARA 2014
  • Fundamental
  • Price
  • RVP $0.79
  • CARA $4.65
  • Analyst Decision
  • RVP
  • CARA Hold
  • Analyst Count
  • RVP 0
  • CARA 3
  • Target Price
  • RVP N/A
  • CARA $12.00
  • AVG Volume (30 Days)
  • RVP 103.9K
  • CARA 331.3K
  • Earning Date
  • RVP 11-14-2024
  • CARA 03-03-2025
  • Dividend Yield
  • RVP N/A
  • CARA N/A
  • EPS Growth
  • RVP N/A
  • CARA N/A
  • EPS
  • RVP N/A
  • CARA N/A
  • Revenue
  • RVP $38,265,097.00
  • CARA $8,686,000.00
  • Revenue This Year
  • RVP N/A
  • CARA N/A
  • Revenue Next Year
  • RVP N/A
  • CARA N/A
  • P/E Ratio
  • RVP N/A
  • CARA N/A
  • Revenue Growth
  • RVP N/A
  • CARA N/A
  • 52 Week Low
  • RVP $0.56
  • CARA $2.71
  • 52 Week High
  • RVP $1.34
  • CARA $13.80
  • Technical
  • Relative Strength Index (RSI)
  • RVP 61.15
  • CARA 52.14
  • Support Level
  • RVP $0.71
  • CARA $4.32
  • Resistance Level
  • RVP $0.80
  • CARA $4.92
  • Average True Range (ATR)
  • RVP 0.06
  • CARA 0.66
  • MACD
  • RVP 0.01
  • CARA -0.10
  • Stochastic Oscillator
  • RVP 72.87
  • CARA 28.75

About RVP Retractable Technologies Inc.

Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. The company's products are the VanishPoint 0.5mL insulin syringe; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL, and 10mL syringes; the small diameter tube adapter; the blood collection tube holder; the allergy tray; the IV safety catheter; the Patient Safe syringes; the Patient Safe Luer Cap; the VanishPoint Blood Collection Set; and the EasyPoint needle, as well as a standard 3mL syringe packaged with an EasyPoint needle. The company also sells VanishPoint autodisable syringes in the international market in addition to the Company's other products.

About CARA Cara Therapeutics Inc.

Cara Therapeutics Inc is a development-stage biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara's objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features.

Share on Social Networks: